1. Home
  2. CCG vs GRDX Comparison

CCG vs GRDX Comparison

Compare CCG & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$8.11

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

SELL

Current Price

$5.59

Market Cap

28.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CCG
GRDX
Founded
2014
N/A
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
28.6M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
CCG
GRDX
Price
$8.11
$5.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.3K
★ 97.4K
Earning Date
09-04-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.95
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.74
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.87
52 Week High
$18.16
$6.93

Technical Indicators

Market Signals
Indicator
CCG
GRDX
Relative Strength Index (RSI) 53.28 69.38
Support Level $0.60 $2.37
Resistance Level $17.56 $6.93
Average True Range (ATR) 0.97 0.52
MACD 0.59 0.10
Stochastic Oscillator 83.46 92.44

Price Performance

Historical Comparison
CCG
GRDX

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: